WOCKPHARMA

Wockhardt : Co's Antibiotic Gets Positive Nod from CDSCO 💊📈 • 🧪 Regulatory Boost: Zaynich receives favourable recommendation from CDSCO expert panel • 🏥 Next Step: Clears path for final approval from DCGI • 🌍 Strong Pipeline: Backed by global Phase 3 trials & strong efficacy data • 🔬 High Impact Drug: Targets drug-resistant Gram-negative infections (XDR/MDR) • 🇺🇸🇪🇺 Global Progress: US & EU filings already in advanced stages 🟢 Impact: Positive Strengthens pharma pipeline, future revenue visibility & global positioning